RECRUITING

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Official Title

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

Quick Facts

Study Start:2025-09-01
Study Completion:2026-02-13
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07102082

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
  2. * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
  3. * Open to trying a non-combusted oral tobacco product.
  4. * Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
  5. * Have the ability to read, write, and communicate in English.
  6. * Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure
  1. * Plan to quit smoking in the next 30 days.
  2. * Use of smokeless tobacco at least weekly in the last 6 months.
  3. * Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
  4. * Unwilling or unable to follow protocol requirements.
  5. * Pregnant or planning to become pregnant (by self report)

Contacts and Locations

Study Contact

ASK RPCI
CONTACT
1-800-767-9355
askroswell@roswellpark.org

Principal Investigator

Richard O'Connor
PRINCIPAL_INVESTIGATOR
Roswell Park

Study Locations (Sites)

Roswell Park
Buffalo, New York, 14206
United States

Collaborators and Investigators

Sponsor: Roswell Park Cancer Institute

  • Richard O'Connor, PRINCIPAL_INVESTIGATOR, Roswell Park

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-01
Study Completion Date2026-02-13

Study Record Updates

Study Start Date2025-09-01
Study Completion Date2026-02-13

Terms related to this study

Additional Relevant MeSH Terms

  • Smoking Behaviors